Abstract
Isolated autosomal recessive woolly hair/hypotrichosis (ARWH, OMIM:278150) is a rare congenital disorder marked by sparse, tightly curled “woolly” hair. ARWH is associated with mutations in LIPH, LPAR6/P2RY5, KRT25, and C3ORF52, with LIPH and LPAR6 as the primary causative genes. Mutation prevalence varies globally: in Japan, founder mutations c.736 T > A (p.Cys246Ser) and c.742C > A (p.His248Asn) in LIPH are predominant; Pakistan reports a recurrent LIPH exon 5 deletion (c.659_660del); Russia’s Volga-Ural region has an exon 4 deletion (c.527_628del); and 12 out of 19 Chinese ARWH cases are linked to LIPH c.742C > A. LPAR6 mutations are sporadic, with rare occurrences in Pakistani families and two Chinese cases. KRT25 mutations include the Russian founder variant c.712G > T (p.Val238Leu) and the Pakistani c.950 T > C (p.Leu317Pro). C3ORF52 mutations are newly identified and reported only in two U. S. cases. No definitive treatment exists, but minoxidil, gentamicin, regenerative therapies, and plant-derived compounds show potential. Regional mutation patterns highlight genetic founder effects and population-specific variations in ARWH pathogenesis.
1 Introduction
Isolated autosomal recessive woolly hair/ hypotrichosis (ARWH, OMIM:278150) is a rare congenital hair abnormality that typically manifests at birth or within the first 2 years of life (1). Clinically, it presents as sparse, thin, and tightly curled hair, resembling sheep’s wool, which may be accompanied by reduced hair pigmentation and increased fragility. Based on presentation and distribution, it can be classified as generalized (affecting the entire scalp and body), localized (confined to a scalp area as a woolly hair nevus), or diffuse partial (primarily occurring in adolescence and adulthood). This condition can occur in isolation or as part of a genetic syndrome and is thus divided into syndrome and non-syndrome forms (2).
In 1907, Gossage first documented this phenomenon in a European family (3). In 1974, Hutchinson et al. classified non-syndromic woolly hair into three types based on genetic characteristics: (1) woolly hair nevus (non-hereditary, OMIM:194050), (2) autosomal dominant woolly hair (ADWH, hereditary, OMIM:194040), and (3) autosomal recessive woolly hair (ARWH, familial, OMIM:278150). Woolly hair nevus presents as well-circumscribed scalp woolly patches (rarely elsewhere) without systemic abnormalities or gene mutations, stabilizing post-childhood without extensive alopecia. Autosomal dominant (ADWH) involves generalized woolly hair (entire scalp, often eyebrows) persisting into adulthood, linked to KRT74 mutations but rarely causing severe hypotrichosis (normal hair density with only texture issues). Autosomal recessive (ARWH) onsets at birth or early infancy, featuring generalized sparse, tightly curled woolly hair and progressive hypotrichosis (age-related thinning), mainly caused by mutations in LIPH, LPAR6 (P2RY5), KRT25, or C3ORF52 (4). Localized autosomal recessive hypotrichosis (LAH) differs from ARWH by focal alopecia (mostly in the scalp parietal region or eyebrows, no generalized woolly hair) and is specifically associated with C3ORF52 mutations. This article reviews and summarizes the literature on the clinical manifestations, diagnosis, genetics, and treatments of isolated ARWH, providing insights for clinical practice.
2 Materials and methods
This study explored the clinical manifestations, diagnosis, genetic pathogenesis, and treatment of ARWH through a comprehensive literature search. Relevant literature was retrieved from databases including CNKI, Wanfang Data, VIP Chinese Journal Database, and PubMed. The search terms used were (“Autosomal Recessive Woolly Hair” OR “ARWH” OR “Woolly Hair Hypotrichosis”), with a publication cutoff of December 2024.
Literature was included based on the following criteria:
-
Publicly published literature with accessible and readable full texts;
-
Original studies, case reports, case series, or reviews focusing on the clinical manifestations, genetic characteristics, diagnosis, or treatment of ARWH;
-
For case reports, clear genetic mutation information must be provided.
To ensure the reliability and validity of the included evidence, the following types of literature were excluded during the screening process:
-
Duplicate reports.
-
Literature on diseases presenting with woolly hair but not ARWH.
-
Undiagnosed case reports.
Finally, 63 English articles and 22 Chinese articles were included, consisting of 63 case reports and 7 reviews.
3 Discussion
3.1 Clinical manifestations of isolated ARWH
ARWH is a rare structural abnormality of the hair shaft with limited growth potential. The main clinical features include abnormal hair characteristics at birth, slow hair growth, and cessation of growth after reaching a certain length (rarely exceeding 12 cm) (4). Hair across the entire scalp is coarse, dry, and lusterless, with spiral or wavy curls resembling scattered sheep’s wool, accompanied by varying degrees of sparseness, increased fragility, and reduced pigmentation. The majority of patients have normal eyebrows, eyelashes, beards, armpit hair, pubic hair, nails, teeth, and sweating function, with rare cases of palmoplantar keratoderma and perifollicular keratosis. Histopathological examination of scalp tissue reveals abnormalities in hair follicles and hair shafts. Most patients have varying degrees of hypotrichosis, with alopecia totalis as the most severe form. Hair condition may improve or worsen with age (5) (Figure 1).
Figure 1
(A,B) ARWH patient’s clinical manifestations; the patient’s hair is curly or wavy, with a “sheep’s wool appearance,” and there are varying degrees of hair thinning.
3.2 Microscopic, scanning electron microscopy (SEM), and trichoscopy characteristics of isolated ARWH
3.2.1 Microscopy
Plucked hairs from affected individuals exhibit a wavy appearance, with most showing signs of nutritional deficiency and absence of root sheath components at the hair bulb.
3.2.2 SEM
Under SEM, ARWH presents the following characteristics (4): (1) flat shape, with oval or irregular cross-section; (2) longitudinal and transverse grooves on the proximal hair shaft, with normal cortical cell striations but worn free edges; (3) uneven and irregular twisting on both proximal and distal hair shafts (distinct from true twisted hair); and (4) possible absence or damage of distal cortical cells leading to hair breakage, presenting as nodular fragile hair, trichorrhexis nodosa, or trichoschisis.
3.2.3 Trichoscopy
Trichoscopic examination reveals intensely wavy, serpentine hairs accompanied by hair shaft breakage. While not essential for diagnosis, the typical wavy hair appearance is suggestive of ARWH and warrants further clinical evaluation (Figure 2).
Figure 2
(A,B) Corresponding hair microscopy findings of two ARWH patients (A) curly hair (red box), wavy hair (red arrow), (B) black spots sign (blue box), broken hair (red box), and wavy hair (red arrow).
3.3 The diagnosis and differential diagnosis of isolated ARWH
The diagnosis of ARWH requires a combination of clinical manifestations and genetic testing, with differentiation from other congenital hair shaft abnormalities. Although ARWH often occurs in isolation, it is crucial to rule out syndrome forms, including Carvajal syndrome (OMIM:605676), Naxos disease (OMIM:601214), ectodermal dysplasia-skin fragility syndrome (ED-SF syndrome, OMIM:604536), tricho-hepato-enteric syndrome (TDOS, OMIM:222470), and Menkes disease (MD, OMIM:309400). Syndromic woolly hair is often characterized by multisystem involvement, frequently accompanied by epidermal and dermal symptoms. For newborns with woolly hair, differentiation can be achieved by assessing for additional systemic manifestations (e.g., hair keratotic disorders, palmoplantar keratoderma, and cardiac or sensory abnormalities) combined with family history and genetic testing.
Carvajal syndrome is mainly characterized by woolly hair, striate palmoplantar keratoderma, and left-sided dilated cardiomyopathy (6). Naxos disease is a right ventricular arrhythmogenic cardiomyopathy associated with diffuse palmoplantar keratoderma and woolly hair. Both conditions are inherited in an autosomal recessive manner, with Naxos disease caused by DSG2 mutations and Carvajal syndrome caused by DSC2 mutations (7). ED-SF syndrome, an autosomal recessive disorder caused by PKP1 mutations, presents with fragile skin, chronic lip inflammation, palmoplantar keratoderma, abnormal hair growth, and nail dystrophy (8). TDOS, caused by dominant DLX3 mutations, is an ectodermal development disorder characterized by dental abnormalities (e.g., enamel hypoplasia and malocclusion), cranial sclerosis, and hair/nail anomalies (2). MD (also known as curly hair syndrome) is a rare X-linked recessive disorder caused by ATP7A mutations, featuring markedly wavy hair, progressive neurodegeneration, and connective tissue abnormalities (9). Additionally, woolly hair can also be seen in rarer syndromes such as Noonan syndrome, cardiofaciocutaneous syndrome, and Costello syndrome, all of which share features of growth retardation, cardiac defects, intellectual disability, and embryonic development abnormalities (Table 1).
Table 1
| Syndrome | Clinical “Red Flags” | Inheritance pattern | Causal gene(s) |
|---|---|---|---|
| Carvajal syndrome | Woolly hair, striate palmoplantar keratoderma, left-sided dilated cardiomyopathy | Autosomal Recessive | DSC2 |
| Naxos disease | Woolly hair, diffuse palmoplantar keratoderma, right ventricular arrhythmogenic cardiomyopathy | Autosomal Recessive | DSG2 |
| ED-SF syndrome | Woolly/abnormal hair, fragile skin, chronic lip inflammation, palmoplantar keratoderma, nail dystrophy | Autosomal Recessive | PKP1 |
| TDOS | Dental abnormalities (enamel hypoplasia, malocclusion), woolly/abnormal hair, cranial sclerosis, nail anomalies | Autosomal Dominant | DLX3 |
| MD | Curly (woolly appearing) hair, progressive neurodegeneration, connective tissue defects | X-linked Recessive | ATP7A |
Key syndromic woolly hair disorders.
Non-syndromic hair shaft abnormalities requiring differentiation include monilethrix, pili torti, trichorrhexis nodosa, pseudopili annulati, and trichothiodystrophy. Monilethrix is identified by periodically narrowed hair shafts, prone to breakage at these narrow sections (10), often accompanied by perifollicular papules and erythema (absent in ARWH). Pili torti involves flattened hair shafts with 90°–360° curls along the axis, which are milder and irregularly spaced compared to ARWH (10). Trichorrhexis nodosa is characterized by longitudinal hair shaft breakage into multiple fibers, producing a “brush-like appearance” under dermatoscopy (11). Pseudopili annulati (bamboo hair) results from hair shaft invagination (stacking) at specific points.
3.4 Genetics of isolated ARWH
Advancements in molecular biology and statistical methods have enhanced the understanding of ARWH pathogenesis through two-point linkage analysis for pathogenic gene localization and cloning. Type 1 autosomal recessive woolly hair (ARWH1, OMIM:278150) is caused by LPAR6 (P2RY5) mutations, type 2 (ARWH2, OMIM:604379) by LIPH mutations, and type 3 (ARWH3, OMIM:616760) by KRT25 mutations. In recent years, missense mutations in C3ORF52 have been identified in ARWH patients from two independent families (4).
The LIPH gene, located on human chromosome 3q27.2, contains 10 exons and encodes a 451-amino acid membrane-bound triacylglycerol lipase. Its primary function is to catalyze phosphatidic acid (PA) hydrolysis to produce 2-acyl lysophosphatidic acid (LPA), an extracellular mediator that promotes hair growth (12). LPA is the ligand for the G protein-coupled receptor P2Y5, encoded by the LPAR6 gene, which is expressed in the Henle, Huxley, and basement membrane layers of the inner hair root sheath. LIPH is also highly expressed in the Huxley layer of the inner hair sheath and outer hair root sheath, suggesting overlapping roles in hair follicle differentiation and maturation via the LIPH/LPA/P2Y5 pathway.
The KRT25 gene encodes keratin 25, a member of the keratin family critical for cytoskeletal formation and maintenance in hair, skin, and nails. Mutations disrupt keratin 25 function, impairing hair cell stability and morphology, causing ARWH (13).
Chromosome 3 Open Reading Frame 52 (C3ORF52) is thought to be necessary for LIPH-mediated LPA synthesis, but its exact function remains unclear. Mutations may affect cell signaling or cytoskeletal structure during hair development, impacting hair morphology (14). Further research is needed to elucidate its specific mechanisms.
Since Kazantseva et al. identified the LIPH gene as a contributor to human hair development defects in 50 families from the Volga-Ural region of Russia in 2006, researchers have continuously explored the pathogenic genes and pathogenesis of ARWH. To date, over 30 LIPH mutations (Table 2), more than 20 LPAR6 gene mutations (Table 3), and 2 mutations each in the KRT25 and C3ORF52 genes (Table 4) have been detected across different regions and ethnic groups. These mutations encompass frameshift, missense, and splice site variants, with homozygous mutations being the most prevalent, followed by compound heterozygous forms. In China, ARWH was first reported by Shen Dawei in 1985; in recent years, with the deepening understanding of woolly hair, 19 ARWH family pedigrees have been documented domestically.
Table 2
| Exon | Mutation | Variation ID/Accession (ClinVar) | Amino acid changes | Variant type | Ethnicity | Founder/Recurrent | Region | Reference |
|---|---|---|---|---|---|---|---|---|
| 2 | c.322 T > C | 3,305/VCV000003305.1 | p.Trp108Arg | Missense | Pakistani | Yes | South Asia | (22) |
| 2 | c.328C > T | 280,138/VCV000280138.4 | p.Arg110* | Nonsense | Pakistani | No | South Asia | (23) |
| 2 | c.346–350delATATA | / | FS/PTC120 | Deletion | Pakistani | No | South Asia | (24) |
| 2 | c.280_369dup | 3,306/VCV000003306.3 | p.Gly94_Lys123dup | In-frame duplication | Pakistani, Israeli, Turkish, Arab, Jewish | Yes | South Asia, Middle East, Europe | (22, 25–28) |
| 2 | c.179C > G | / | p.Ser60* | Nonsense | Lebanese | No | South Asia | (29) |
| 2 | c.403_409dup | / | p.Gln137HisfsX1 | Frame-shift | Austrian | No | Europe | (28) |
| 3 | c.460_461AG > GA | / | p.Ser154Asp | Missense | Japanese | No | East Asia | (30) |
| 3 | c.454G > A | / | p.Gly152Arg | Missense | Chinese | No | East Asia | (31) |
| 4 | c.624delT | / | FS/PTC217 | Deletion | Pakistani | No | South Asia | (5) |
| 4 | c.558_559insT | / | p.Lys187Ter | Missense | Japanese | No | East Asia | (32) |
| 4 | c.527_628del | / | 176G-209D(34aa)deletion | Deletion | Russian | Yes | Europe | (33) |
| 4 | c.614A > G | / | p.His205Arg | Missense | Japanese, Chinese | No | East Asia | (34, 35) |
| 4 | c.619G > C | / | p.Asp207His | Missense | Japanese | No | East Asia | (36) |
| 4 | c.530 T > G | / | p.Leu177Arg | Missense | Chinese | No | East Asia | (37) |
| 5 | c.659_660delTA | / | p.Ile220Argfs*29 | Deletion | Pakistani, Guyanese | Yes | South Asia, South America | (22, 38) |
| 5 | c.682delT | / | FS/PTC259 | Deletion | Pakistani | No | South Asia | (5) |
| 5 | c.688C > T | / | p.Gln230* | Nonsense | Pakistani | No | South Asia | (39) |
| 5 | c.686delAins18 | / | p.Asp229Glyfs*22 | Frame-shift | Japanese | No | East Asia | (40) |
| 5 | c.699C > G | / | p.Cys233Trp | Missense | Japanese | No | East Asia | (41) |
| 5 | c.671C > G | / | p.Pro224Arg | Missense | Japanese | No | East Asia | (42) |
| 5 | c.686delinsGTAGAACCCAACCTGGCT | 3,775,180/VCV003775180.1 | p.Asp229fs37X | Frame-shift | Chinese | No | East Asia | (43) |
| 5 | c.629-1_629delinsTT | / | Not reported | Splice | Chinese | No | East Asia | (44) |
| 6 | c.778A > T | / | p.Arg260X | Nonsense | Pakistani | No | South Asia | (22) |
| 6 | c.736 T > A | 225,403/VCV000225403.9 | p.Cys246Ser | Missense | Japanese, Chinese | Yes | East Asia | (32, 45) |
| 6 | c.742C > A | 30,669/VCV000030669.6 | p.His248Asn | Missense | Japanese, Chinese | Yes | East Asia | (30, 46) |
| 7 | c.932delC | / | p.Pro311Leufs*3 | Deletion | Pakistani | No | South Asia | (47) |
| 7 | c.973C > T | / | p.Pro325Ser | Missense | Chinese | No | East Asia | (48) |
| 7 | c.982 + 12A > G | / | Not reported | Splice | Chinese | No | East Asia | (44) |
| 7, 8 | Ex7_8del | / | FS/PTC297 | Deletion | Pakistani, Guyanese | Yes | South Asia, South America | (5, 49) |
| 10 | c.1303_1309dupGAAAACG | / | Val437GlyfsX4 | Insertion | Guyanese | No | South America | (38) |
| Intron 2 | c.417 + 1G > C | / | Not reported | Splice | Japanese | No | East Asia | (50) |
| Intron 4 | c.620_627delACACTGATinsCTCCTTTCCTTGTG | / | p.207_209delDTDinsAPFLV | Deletion/Insertion mutation | Italian | No | Europe | (27) |
| Intron 7 | c.982 + 5G > T | / | p.Met328Serfs41X | Splice | Japanese | No | East Asia | (51) |
| Intron 7 | c.982 + 2 T > A | / | p.Gly296Val | Splice | Japanese | No | East Asia | (52) |
| Intron 7 | c.982 + 7_ + 21del | / | p.Tyr297_Met328delel | Splice | Japanese | No | East Asia | (52) |
| Intron 8 | c.1095-3C > G | / | p.Glu366Ilefs*7 | Splice | Japanese | No | East Asia | (53) |
Reported LIPH gene mutations in international patients with ARWH.
*indicates a nonsense mutation that results in a premature termination codon.
Table 3
| Mutation | Variation ID/Accession (ClinVar) | Amino acid changes | Variant type | Ethnicity or geographical area | Founder/Recurrent | Region | Reference |
|---|---|---|---|---|---|---|---|
| c.436G > A | 1828/VCV000001828.4 | p.Gly146Arg | Missense | Pakistani, Iranian | Yes | South Asia, Middle East | (54, 55) |
| c.47A > T | / | p.Lys16Met | Missense | Pakistani | No | South Asia | (54) |
| c.734A > G | / | p.Tyr245Cys | Missense | Pakistani | No | South Asia | (49) |
| c.66_69insCATG | / | p.Phe24HisfsX28 | Frame-shift | Pakistani | Yes | South Asia | (56) |
| c.160insA | / | p.N54TfsX58 | Frame-shift | Pakistani | No | South Asia | (57) |
| c.36insA | / | p.D13RfsX16 | Frame-shift | Pakistani | No | South Asia | (57) |
| c.565G > A | 1829/VCV000001829.3 | p. Glu189Lys | Missense | Pakistani | No | South Asia | (57) |
| c.8G > C | 2,505,339/VCV002505339.1 | p.Ser3Thr | Missense | Pakistani | No | South Asia | (57) |
| c.188A > T | 217,499/VCV000217499.3 | p. Asp63Val | Missense | Pakistani | Yes | South Asia | (56) |
| c.562A > T | 1827/VCV000001827.4 | p.Ile188Phe | Missense | Pakistani | Yes | South Asia | (56) |
| c.69insCATG | / | p.24insHfs52 | Frame-shift | Pakistani | Yes | South Asia | (49) |
| c.68_69insGCAT | / | p.Phe24Hisfs*29 | Frame-shift | Pakistani | No | South Asia | (39) |
| c.409 T > C | / | Not reported | Missense | Pakistani | No | South Asia | (49) |
| c.410-426del17 | / | Not reported | Deletion | Pakistani | No | South Asia | (49) |
| c.373_374delAA | / | p.Lys125fs | Deletion | Saudi, Arab | No | Middle East | (58) |
| c.472delC | / | p.His158ThrfsX27 | Deletion | Turkish | No | Middle East | (59) |
| c.64_67dupTGCA | / | p.Phe24HisfsX28 | Duplication | Indian | No | South Asia | (59) |
| c.669_672delCAAA | / | p.Asn223LysfsX7 | Deletion | Israeli | No | Middle East | (60) |
| c.756 T > A | / | p.Tyr252* | Nonsense | Japanese | No | East Asia | (61) |
| c.736A > G | 3,768,194/VCV003768194.1 | p.Cys246Ser | Missense | Spanish | No | Europe | (62) |
| c.859G > C | / | p.Asp287His | Missense | Spanish | No | Europe | (62) |
| Not reported | / | p.C278Y | Missense | Brazilian | No | South America | (63) |
| c.377C > G | / | p.Thr126Ser | Missense | Chinese | No | East Asia | (64) |
| c.328-330delATT | / | p.Ile110del | Deletion | Chinese | No | East Asia | (65) |
Reported LPAR6 gene mutations in patients with ARWH.
Table 4
| Causative gene | Mutation | Variation ID/Accession(ClinVar) | Amino acid changes | Variant type | Ethnicity or geographical area | Founder/Recurrent | Region | Reference |
|---|---|---|---|---|---|---|---|---|
| KRT25 | c.712G > T | 242,934/VCV000242934.5 | p.Val238Leu | Missense | Russian | No | Europe | (15) |
| KRT25 | c.950 T > C | 217,303/VCV000217303.3 | p.Leu317Pro | Missense | Pakistani | No | East Asia | (16) |
| C3ORF52 | c.492 T > A | 1,806,468/VCV001806468.1 | p.Tyr164Ter | Nonsense | Hispanic American | No | North America | (17) |
| C3ORF52 | c.34G > T | 1,806,469/VCV001806469.2 | p.Glu12Ter | Nonsense | Arab Muslim ancestry American | No | North America | (17) |
Reported C3ORF52 and KRT25 gene mutations in international patients with ARWH.
Notably, the frequency of pathogenic gene mutations in ARWH patients varies by ethnicity and geographical region. LIPH mutations have been most frequently reported in Pakistan, Japan, China, and Russia, as well as in Italy, India, Austria, Lebanon, Arabia, Jewish populations, and Guyana. High incidences of LIPH mutations in ARWH pedigrees have been observed in populations from Japan, Pakistan, and the Volga-Ural region of Russia. In the Japanese population, LIPH mutations predominantly occur in exon 6: the c.736 T > A (p.Cys246Ser) variant is the most frequently reported, followed by c.742C > A (p.His248Asn), which are recognized as the primary genetic etiologies. Missense and splice site mutations are the dominant types, and there are numerous cases of compound mutations involving two exons or one exon combined with one intron. In Pakistan, all reported LIPH mutations are homozygous, primarily consisting of deletion variants in different exons. Over half of Pakistani ARWH families carry the exon 5 deletion mutation c.659_660delTA (p.Ile220Argfs*29). In the Volga-Ural region of Russia, most ARWH families harbor the exon 4 deletion c.527_628del. In China, 19 ARWH cases have been reported to date, all of which involve LIPH mutations. Among these, patients from 12 unrelated families carry either a homozygous c.742C > A (p.His248Asn) mutation or a compound heterozygous genotype consisting of c.742C > A and another functionally deficient variant. The second most common mutation is c.736 T > A (p.Cys246Ser), consistent with the mutation spectrum observed in the Japanese population. Additional genetic testing data are required to confirm potential founder mutations in the Chinese population.
LPAR6 mutations in ARWH pedigrees have been reported in Pakistan, Saudi Arabia, Iran, Türkiye, India, Israel, Japan, Spain, Brazil, and China; however, a high incidence of LPAR6 mutations has been documented only in the Pakistani population, with 14 distinct variants identified. Missense mutations are the predominant type, and no high-frequency recurrent variants or confirmed founder mutations have been identified. Domestically, LPAR6 mutations have only been detected in two ARWH cases.
In 2016, Nikolay V et al. collected data from 119 individuals presenting with hypotrichosis during a field survey in the Volga-Ural region of Russia. In a group of patients who displayed a phenotype similar to conventional hypotrichosis but had some differences, a previously unreported homozygous mutation c.712G > T was detected within the KRT25 gene, resulting in the p.Val238Leu substitution in the K25 protein. This gene encodes type I (acidic) keratin. Furthermore, the KRT25 mutation c.712G > T was found in isolated populations in the Volga-Ural region, suggesting a founder effect (15). Additionally, Ansar et al. (16) reported a homozygous K25 missense mutation (p.Leu317Pro) in two unrelated Pakistani ARWH families.
In 2020, Malki et al. first identified homozygous variants in C3ORF52 in four individuals with LAH and discovered that C3ORF52 is coexpressed with lipase H in the inner root sheath of the hair follicle, with these two proteins directly interacting. They proposed that lipase H, C3ORF52, and LPAR6 are equally important for normal hair growth. Moreover, PA and LPA have been shown to promote the formation of mouse hair follicles, making these molecules potential targets for the treatment of LAH and other hair disorders (17).
3.5 Treatments for isolated ARWH
ARWH treatment remains challenging, though some patients experience gradual hair improvement with age (18). Currently, no sufficiently effective standardized treatment exists.
3.5.1 Evidence-supported options
Topical minoxidil (1, 2%, or 5% solutions/gels) is applied to the affected scalp areas once or twice daily. Studies show that four Japanese ARWH patients with LIPH mutations achieved significant hair growth with 1% or 5% minoxidil over 6 months to 3 years, with no adverse effects (19). Note that minoxidil is labeled for androgenetic alopecia; its use for LIPH-associated ARWH and congenital hypotrichosis is off-label.
3.5.2 Emerging/experimental options
Gentamicin’s therapeutic value was first validated in hypotrichosis simplex of the scalp: in vitro experiments showed it induces read-through activity targeting CDSN mutations, restoring partial protein function and improving hair symptoms (20). Theoretically, it could benefit ARWH patients with similar nonsense mutations, but no direct clinical or in vitro data confirmed efficacy for ARWH-related mutations.
Regenerative medicine techniques such as platelet-rich plasma therapy (PRP), human hair follicle stem cells (HFSCs), microneedling, and low-level laser therapy (LLL-T) may promote hair regeneration (21). Our team previously reported safe and satisfactory efficacy of a combined traditional Chinese medicine (TCM) regimen: topical “Hair Growth Tincture” (a China-Japan Friendship Hospital-developed external preparation containing Psoraleae Fructus, Rhododendri Mollis Flos, Zingiberis Rhizoma Recens, and 75% ethanol) plus oral paeoniflorin capsules and compound glycyrrhizin tablets (21). However, the majority of studies are small-sample case reports, with unconfirmed efficacy stability and reproducibility.
With the advancing research on the LIPH/LPA/P2Y5 signaling pathway and ARWH pathogenesis, targeted drugs regulating this pathway may become potential treatments.
4 Conclusion
From the existing studies summarized, a preliminary understanding of ARWH, including its clinical features, genetic patterns, and potential treatments, has been established, yet a clear gap remains between mechanistic research and clinical practice. Genetically, while region-specific mutation patterns of genes such as LIPH and LPAR6 (e.g., the high prevalence of LIPH c.742C > A in the Chinese population) highlight genetic founder effects, the link between specific mutations and clinical phenotypes (e.g., hair sparseness severity and age-related changes) remains unclear. This hinders genotype-based disease progression prediction and personalized clinical intervention.
Treatment-related limitations are more notable. Topical minoxidil’s efficacy in LIPH-mutated patients is only supported by small-sample, short-term observations, with its long-term safety and applicable mutation range unconfirmed. Gentamicin’s theoretical value, based on nonsense mutation correction, lacks validation in ARWH patients, leaving its effectiveness across mutation backgrounds unknown. Meanwhile, TCM compounds and regenerative therapies lack standardized protocols and controlled studies, making efficacy reproducibility hard to assess. As a result, current treatments remain “symptomatic trials” without evidence-based standardized regimens.
Additionally, although the diagnostic system emphasizes the integration of “clinical manifestations-microscopic examination-genetic testing,” practical application faces challenges, including ambiguous terminology and inconsistent gene variant classification standards. These issues reduce data comparability across studies and may cause misdiagnosis or missed diagnosis. Future research should focus on three priorities: clarifying genotype–phenotype associations to build genotyping-based prognostic models; conducting multi-center, large-sample trials to validate existing treatments and explore targeted drugs for pathways such as LIPH/LPA/P2Y5; and establishing unified diagnostic terminology and standards to enable integrated data analysis, ultimately bridging the gap from ARWH mechanistic research to standardized clinical management.
As a review, this study has limitations: (1) No pre-defined protocol leads to subjective bias in literature screening, potentially omitting negative results or regional studies; (2) restricted to CNKI, PubMed, and pre-December 2024 publications, missing non-Chinese/English or non-mainstream database studies; (3) included evidence consists mostly of short-follow-up case reports or series (lacking high-quality data such as randomized controlled trials), with publication bias overstating treatment efficacy; (4) inconsistent ARWH terminology, diagnostic criteria, and variant classification reducing data reliability; (5) treatments rely on off-label use or extrapolation from other diseases, lacking direct ARWH evidence; and (6) genetic data, affected by region/founder effects, lack quantitative analysis, limiting representativeness of global ARWH genetic features.
Statements
Author contributions
YXi: Writing – original draft, Writing – review & editing. SLu: Writing – original draft, Writing – review & editing. YY: Writing – original draft. XZ: Writing – review & editing. SLv: Writing – review & editing. MD: Writing – review & editing. YXu: Writing – review & editing. XS: Writing – review & editing. CQ: Writing – review & editing. NL: Writing – review & editing. DY: Writing – review & editing.
Funding
The author(s) declare that no financial support was received for the research and/or publication of this article.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Generative AI statement
The authors declare that no Gen AI was used in the creation of this manuscript.
Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
References
1.
Reda AM Rogers RS Peters MS . Woolly hair nevus. J Am Acad Dermatol. (1990) 22:377–80. doi: 10.1016/0190-9622(90)70053-k
2.
Perandones-González H Rusiñol-Batlle L Bosquez D Brunet-Llobet L Ivars M Yubero D et al . Woolly hair in tricho-dento-osseous syndrome. Pediatr Dermatol. (2023) 40:1094–6. doi: 10.1111/pde.15309
3.
Huang J Li T Tan Z Tang Y Li J Liu F et al . Effectiveness of tofacitinib in pre-adolescent alopecia areata: a retrospective case series and literature review. Acta Derm Venereol. (2023) 103:adv13418–1718. doi: 10.2340/actadv.v103.13418
4.
Akiyama M . Isolated autosomal recessive woolly hair/hypotrichosis: genetics, pathogenesis and therapies. Acad Dermatol Venereol. (2021) 35:1788–96. doi: 10.1111/jdv.17350
5.
Shimomura Y Wajid M Petukhova L Shapiro L Christiano AM . Mutations in the lipase H gene underlie autosomal recessive woolly hair/hypotrichosis. J Invest Dermatol. (2009) 129:622–8. doi: 10.1038/jid.2008.290
6.
Stokes DL . Desmosomes from a structural perspective. Curr Opin Cell Biol. (2007) 19:565–71. doi: 10.1016/j.ceb.2007.09.003
7.
Protonotarios I Asimaki A Xylouri Z Protonotarios A Tsatsopoulou A . Clinical and molecular aspects of naxos disease. Heart Fail Clin. (2022) 18:89–99. doi: 10.1016/j.hfc.2021.07.010
8.
Cuenca-Barrales C Monserrat-García MT Domínguez-Cruz JJ Suñol-Capella M Zulueta-Dorado T Fernández R et al . Ectodermal dysplasia-skin fragility syndrome: two new cases with a novel missense mutation. JDDG J Dtsch Dermatol Ges. (2021) 19:595–7. doi: 10.1111/ddg.14315
9.
Proud VK Mussell HG Kaler SG Young DW Percy AK . Distinctive menkes disease variant with occipital horns: delineation of natural history and clinical phenotype. Am J Med Genet. (1996) 65:44–51. doi: 10.1002/(SICI)1096-8628(19961002)65:1<44::AID-AJMG7>3.0.CO;2-Y
10.
Singh G, Miteva M. Prognosis and management of congenital hair shaft disorders with fragility-part I. Pediatr Dermatol2016;33:473–480. doi: 10.1111/pde.12894
11.
Chen X Pang J Li J Wang X Mi Z Hu Z et al . Mesenchymal stem cell exosomes therapy for acquired trichorrhexis nodosa: a case series. J Cosmet Dermatol. (2024) 24:e16683. doi: 10.1111/jocd.16683
12.
Takahashi T Kamimura A Hamazono-Matsuoka T Honda S . Phosphatidic acid has a potential to promote hair growth in vitro and in vivo, and activates mitogen-activated protein kinase/extracellular signal-regulated kinase kinase in hair epithelial cells. J Invest Dermatol. (2003) 121:448–56. doi: 10.1046/j.1523-1747.2003.12426.x
13.
Shimomura Y Wajid M Petukhova L Kurban M Christiano AM . Autosomal-dominant woolly hair resulting from disruption of keratin 74 (KRT74), a potential determinant of human hair texture. Am J Hum Genet. (2010) 86:632–8. doi: 10.1016/j.ajhg.2010.02.025
14.
Malki L Sarig O Cesarato N Mohamad J Canter T Assaf S et al . Loss-of-function variants in C3ORF52 result in localized autosomal recessive hypotrichosis. Genet Med. (2020) 22:1227–34. doi: 10.1038/s41436-020-0794-5
15.
Zernov NV Skoblov MY Marakhonov AV Shimomura Y Vasilyeva TA Konovalov FA et al . Autosomal recessive hypotrichosis with woolly hair caused by a mutation in the keratin 25 gene expressed in hair follicles. J Invest Dermatol. (2016) 136:1097–105. doi: 10.1016/j.jid.2016.01.037
16.
Ansar M Raza SI Lee K Irfanullah N Shahi S Acharya A et al . A homozygous missense variant in type I keratin KRT25 causes autosomal recessive woolly hair. J Med Genet. (2015) 52:676–80. doi: 10.1136/jmedgenet-2015-103255.
17.
Malki L, Sarig O, Cesarato N, Mohamad J, Canter T, Assaf S et alLoss-of-function variants in C3ORF52 result in localized autosomal recessive hypotrichosis. Genet Med: Off J Am Coll Med Genet2020;22:1227–1234. doi: 10.1038/s41436-020-0794-5
18.
Matsuno N Kunisada M Kanki H Simomura Y Nishigori C . A case of autosomal recessive woolly hair/hypotrichosis with alternation in severity: deterioration and improvement with age. Case Rep Dermatol. (2013) 5:363–7. doi: 10.1159/000357208
19.
Tanahashi K Sugiura K Akiyama M . Topical minoxidil improves congenital hypotrichosis caused by LIPH mutations. Br J Dermatol. (2015) 173:865–6. doi: 10.1111/bjd.13790
20.
Choi SY No YA Kim BJ Kim MN Hong CK . Topical minoxidil and tretinoin combined with an oral vitamin D analog as a treatment for woolly hair. Dermatol Ther. (2016) 29:304–5. doi: 10.1111/dth.12329
21.
Qu B Meng S Yang C Lv S Lin W Yang D . Botanical extracts in combination improve autosomal recessive woolly hair/hypotrichosis caused by LIPH mutations. J of Cosmetic Dermatology. (2022) 21:5255–8. doi: 10.1111/jocd.14880
22.
Tariq M Azhar A Baig SM Dahl N Klar J . A novel mutation in the lipase H gene underlies autosomal recessive hypotrichosis and woolly hair. Sci Rep. (2012) 2:730. doi: 10.1038/srep00730
23.
Mehmood S Jan A Muhammad D Ahmad F Mir H Younus M et al . Mutations in the lipase-H gene causing autosomal recessive hypotrichosis and woolly hair. Australas J Dermatol. (2015) 56:e66–70. doi: 10.1111/ajd.12157
24.
Ali G Chishti MS Raza SI John P Ahmad W . A mutation in the lipase H (LIPH) gene underlie autosomal recessive hypotrichosis. Hum Genet. (2007) 121:319–25. doi: 10.1007/s00439-007-0344-0
25.
Nahum S Pasternack SM Pforr J Indelman M Wollnik B Bergman R et al . A large duplication in LIPH underlies autosomal recessive hypotrichosis simplex in four middle eastern families. Arch Dermatol Res. (2009) 301:391–3. doi: 10.1007/s00403-008-0903-9
26.
Petukhova L Shimomura Y Wajid M Gorroochurn P Hodge SE Christiano AM . The effect of inbreeding on the distribution of compound heterozygotes: a lesson from lipase H mutations in autosomal recessive woolly hair/hypotrichosis. Hum Hered. (2009) 68:117–30. doi: 10.1159/000212504
27.
Horev L Tosti A Rosen I Hershko K Vincenzi C Nanova K et al . Mutations in lipase H cause autosomal recessive hypotrichosis simplex with woolly hair. J Am Acad Dermatol. (2009) 61:813–8. doi: 10.1016/j.jaad.2009.04.020
28.
Pasternack SM Von Kügelgen I Müller M Oji V Traupe H Sprecher E et al . In vitro analysis of LIPH mutations causing hypotrichosis simplex: evidence confirming the role of lipase H and lysophosphatidic acid in hair growth. J Invest Dermatol. (2009) 129:2772–6. doi: 10.1038/jid.2009.154
29.
Sleiman MB Sleiman MB Abbas O Btadini W Najjar T Tofaili M et al . Novel mutation in LIPH in a lebanese patient with autosomal recessive woolly hair/hypotrichosis. J Dermatol. (2015) 42:822–4. doi: 10.1111/1346-8138.12939
30.
Hayashi R Akasaka T Ito M Shimomura Y . Compound heterozygous mutations in two distinct catalytic residues of the LIPH gene underlie autosomal recessive woolly hair in a J apanese family. J Dermatol. (2014) 41:937–8. doi: 10.1111/1346-8138.12612
31.
Ma JH Xiao SX An AJ et al . A case of woolly hair[J]. Journal of Clinical Dermatology, (2009) 38(9):599. doi: 10.3969/j.issn.1000-4963.2009.09.022.
32.
Takeichi T Tanahashi K Taki T Kono M Sugiura K Akiyama M . Mutational analysis of 29 patients with autosomal-recessive woolly hair and hypotrichosis: LIPH mutations are extremely predominant in autosomal-recessive woolly hair and hypotrichosis in Japan. Br J Dermatol. (2017) 177:290–2. doi: 10.1111/bjd.15070
33.
Kazantseva A Goltsov A Zinchenko R Grigorenko AP Abrukova AV Moliaka YK et al . Human hair growth deficiency is linked to a genetic defect in the phospholipase gene LIPH. Sci (N Y NY). (2006) 10:982–5.
34.
Yamaguchi N Kiniwa Y Hayashi R Abe R Katsuie S Okuyama R . Case of autosomal recessive woolly hair/hypotrichosis with compound heterozygous mutations in the LIPH gene at c.742C > a and c.614A > G: the first japanese case. J Dermatol. (2023) 50:e238–9. doi: 10.1111/1346-8138.16761
35.
Chang X Dan Juan GY Dai S Rong CX Lei ZC et al . Novel mutations in the lipase H gene lead to secretion defects of LIPH in Chinese patients with autosomal recessive woolly hair/hypotrichosis (ARWH/HT). Mutagenesis. (2017) 32:599–606. doi: 10.1093/mutage/gex043
36.
Shinkuma S Inoue A Aoki J Nishie W Natsuga K Ujiie H et al . The β9 loop domain of PA-PLA1α has a crucial role in autosomal recessive woolly hair/hypotrichosis. J Invest Dermatol. (2012) 132:2093–5. doi: 10.1038/jid.2012.96
37.
Li Z Wang J Li Z Dou J Qin Z Wu S et al . Detection of Gene Mutations in a Family with Autosomal Recessive Woolly Hair. Chin J Dermatol. (2021) 54:145–7.
38.
Shimomura Y Wajid M Zlotogorski A Lee YJ Rice RH Christiano AM . Founder mutations in the lipase H gene in families with autosomal recessive woolly hair/hypotrichosis. J Invest Dermatol. (2009) 129:1927–34. doi: 10.1038/jid.2009.19
39.
Ahmad F Sharif S Furqan Ubaid M Shah K Khan MN Umair M et al . Novel sequence variants in the LIPH and LPAR6 genes underlies autosomal recessive woolly hair/hypotrichosis in consanguineous families. Congenit Anom. (2018) 58:24–8. doi: 10.1111/cga.12226
40.
Ito T Shimomura Y Hayashi R Tokura Y . Identification of a novel mutation, c.686delAins18 (p.Asp229Glyfs*22), in theLIPHgene as a compound heterozygote with c.736T>a (p.Cys246Ser) in autosomal recessive woolly hair/hypotrichosis. J Dermatol. (2015) 42:752–3. doi: 10.1111/1346-8138.12889
41.
Yoshizawa M Nakamura M Farooq M Inoue A Aoki J Shimomura Y . A novel mutation, c.699C>G (p.C233W), in the LIPH gene leads to a loss of the hydrolytic activity and the LPA6 activation ability of PA-PLA1α in autosomal recessive wooly hair/hypotrichosis. J Dermatol Sci. (2013) 72:61–4. doi: 10.1016/j.jdermsci.2013.05.001
42.
Minakawa S Matsuzaki Y Higashino T Suzuki T Tomita H Akasaka E et al . Case report: exploring autosomal recessive woolly hair: genetic and scanning electron microscopic perspectives on a japanese patient. Front Med. (2024) 11:1374222. doi: 10.3389/fmed.2024.1374222
43.
Lv H Li M Cheng R . Novel small-insertion mutation in the LIPH gene in a patient with autosomal recessive woolly hair/hypotrichosis. J Dermatol. (2020) 47:1445–9. doi: 10.1111/1346-8138.15581
44.
Zhao AQ Cao QY Zheng LY Liu QM Li M Wu WY et al . Genetic mutation analysis of two families with autosomal recessive woolly hair associated with hypotrichosis. Chin J Lepr Skin Dis. (2024) 40:234–8. doi: 10.12144/zgmfskin202404234
45.
Liu MM Wang L Liu L . A case of autosomal recessive hypotrichosis type 7 and literature review. Bull Dermatol Sci. (2020) 37:141–4.
46.
Chen X Li XQ Yao XY Yu C Zhang JZ Zhou C . A case of autosomal recessive woolly hair caused by Liph gene mutation. Chin J Dermatovenereol. (2020) 34:299–301. doi: 10.13735/j.cjdv.1001-7089.201905154
47.
Mehmood S Shah SH Jan A Younus M Ahmad F Ayub M et al . Frameshift sequence variants in the human lipase-H gene causing hypotrichosis. Pediatr Dermatol. (2016) 33:e40–2. doi: 10.1111/pde.12727
48.
Yu C Wen GD Yao XY Xu HJ Zhang JZ Zhou C . A case of autosomal recessive woolly hair and study on gene mutation. J Clinic Dermatol. (2019) 48:269–73. doi: 10.16761/j.cnki.1000-4963.2019.05.004
49.
Kurban M Wajid M Shimomura Y Christiano AM . Mutations in LPAR6/P2RY5 and LIPH are associated with woolly hair and/or hypotrichosis. Acad Dermatol Venereol. (2013) 27:545–9. doi: 10.1111/j.1468-3083.2012.04472.x
50.
Matsuo Y Tanaka A Shimomura Y Hide M . Novel splice site mutation in LIPH identified in a japanese patient with autosomal recessive woolly hair. J Dermatol. (2016) 43:1384–5. doi: 10.1111/1346-8138.13373
51.
Hayashi R Inui S Farooq M Ito M Shimomura Y . Expression studies of a novel splice site mutation in the LIPH gene identified in a japanese patient with autosomal recessive woolly hair. J Dermatol. (2014) 41:890–4. doi: 10.1111/1346-8138.12623
52.
Asano N Okita T Yasuno S Yamaguchi M Kashiwagi K Kanekura T et al Identification of a novel splice site mutation in the LIPH gene in a Japanese family with autosomal recessive woolly hair. J Dermatol [Internet]. 2019;46:e19–e20. doi: 10.1111/1346-8138.14534
53.
Mizukami Y Hayashi R Tsuruta D Shimomura Y Sugawara K . Novel splice site mutation in the LIPH gene in a patient with autosomal recessive woolly hair/hypotrichosis: case report and published work review. J Dermatol. (2018) 45:613–7. doi: 10.1111/1346-8138.14257
54.
Khan GM Hassan N Khan N Humayun M Khan K Khaliq S et al . Biallelic mutations in the LPAR6 gene causing autosomal recessive wooly hair/hypotrichosis phenotype in five Pakistani families. Int J Dermatol. (2019) 58:946–52. doi: 10.1111/ijd.14480
55.
Shimomura Y Garzon MC Kristal L Shapiro L Christiano AM . Autosomal recessive woolly hair with hypotrichosis caused by a novel homozygous mutation in the P2RY5 gene. Exp Dermatol. (2009) 18:218–21. doi: 10.1111/j.1600-0625.2008.00788.x
56.
Khan S Habib R Mir H Umm-e-Kalsoom N Naz G Ayub M et al . Mutations in the LPAR6 and LIPH genes underlie autosomal recessive hypotrichosis/woolly hair in 17 consanguineous families from Pakistan. Clin Exp Dermatol. (2011) 36:652–4. doi: 10.1111/j.1365-2230.2011.04014.x
57.
Raza S. I. Muhammad D. Jan A. Ali R. H. Hassan M. Ahmad W. et al In silico analysis of missense mutations in LPAR6 reveals abnormal phospholipid signaling pathway leading to hypotrichosis. Van Steensel MAM, editor. PLoS One2014;9:e104756. doi: 10.1371/journal.pone.0104756
58.
Alsharif O Ahmed AA Alali AM Kaki AA . Unusual clinical presentation of autosomal recessive woolly hair. Skin Appendage Disord. (2020) 6:120–2. doi: 10.1159/000505134
59.
Pasternack SM Murugusundram S Eigelshoven S Müller M Kruse R Lehmann P et al . Novel mutations in the P2RY5 gene in one turkish and two Indian patients presenting with hypotrichosis and woolly hair. Arch Dermatol Res. (2009) 301:621–4. doi: 10.1007/s00403-009-0971-5
60.
Horev L Saad-Edin B Ingber A Zlotogorski A . A novel deletion mutation in P2RY5/LPA(6) gene cause autosomal recessive woolly hair with hypotrichosis. J Eur Acad Dermatol Venereol. (2010) 24:858–9. doi: 10.1111/j.1468-3083.2009.03514.x
61.
Hayashi R Inoue A Suga Y Aoki J Shimomura Y . Analysis of unique mutations in the LPAR6 gene identified in a japanese family with autosomal recessive woolly hair/hypotrichosis: establishment of a useful assay system for LPA6. J Dermatol Sci. (2015) 78:197–205. doi: 10.1016/j.jdermsci.2015.03.006
62.
Piquer-García J Torres-Navarro I Martínez-Castellano F Évole-Buselli M . Autosomal recessive woolly hair and hypotrichosis in two Caucasian dizygotic twins. Description of a novel biallelic mutation in the LPAR6 gene. Int J Dermatol. (2021). 60:e68–e70. doi: 10.1111/ijd.15207
63.
Petukhova L Sousa EC Martinez-Mir A Vitebsky A Dos Santos LG Shapiro L et al . Genome-wide linkage analysis of an autosomal recessive hypotrichosis identifies a novel P2RY5 mutation. Genomics. (2008) 92:273–8. doi: 10.1016/j.ygeno.2008.06.009
64.
Pan YX Lin ZM Yang SX . Family investigation and LIPH gene mutation analysis of autosomal recessive woolly hair. Journal of Clinical Dermatology. (2019) 48:402–6. doi: 10.16761/j.cnki.1000-4963.2019.07.003
65.
Liu LH Chen G Wang JW Liu SX Wang JB Zhou FS et al . A novel deletion mutation in the LPAR6 gene underlies autosomal recessive woolly hair with hypotrichosis. Clin Exp Dermatol. (2013) 38:796–8. doi: 10.1111/ced.12129
Summary
Keywords
autosomal recessive woolly hair, diagnostic, genetic, treatment, ARWH
Citation
Xie Y, Luo S, Yang Y, Zou X, Lv S, Du M, Xu Y, Song X, Qi C, Li N and Yang D (2025) Diagnosis and treatment of isolated autosomal recessive woolly hair/hypotrichosis. Front. Med. 12:1605851. doi: 10.3389/fmed.2025.1605851
Received
04 April 2025
Revised
08 November 2025
Accepted
10 November 2025
Published
05 December 2025
Volume
12 - 2025
Edited by
David Saceda Corralo, Hospital Ramón y Cajal, Spain
Reviewed by
Piotr K. Krajewski, Wroclaw Medical University, Poland
Beata Jastrząb-Miśkiewicz, Wrocław Medical University, Poland
Updates
Copyright
© 2025 Xie, Luo, Yang, Zou, Lv, Du, Xu, Song, Qi, Li and Yang.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Nuo Li, nola8316@sina.comDingquan Yang, ydqlx@163.com
†These authors share first authorship
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.